RACANELLI, Vito
 Distribuzione geografica
Continente #
NA - Nord America 14.769
EU - Europa 6.857
AS - Asia 5.831
SA - Sud America 1.461
AF - Africa 271
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 29.204
Nazione #
US - Stati Uniti d'America 14.517
SG - Singapore 2.437
RU - Federazione Russa 1.944
IT - Italia 1.795
CN - Cina 1.384
BR - Brasile 1.163
SE - Svezia 899
HK - Hong Kong 713
DE - Germania 545
FR - Francia 397
VN - Vietnam 360
FI - Finlandia 329
GB - Regno Unito 317
UA - Ucraina 252
IN - India 201
BD - Bangladesh 125
CA - Canada 123
ID - Indonesia 97
AR - Argentina 95
TR - Turchia 73
PL - Polonia 68
IQ - Iraq 67
JP - Giappone 67
ZA - Sudafrica 67
MX - Messico 66
BE - Belgio 62
CI - Costa d'Avorio 55
CO - Colombia 50
PK - Pakistan 49
ES - Italia 46
VE - Venezuela 44
NL - Olanda 43
MA - Marocco 40
EC - Ecuador 39
SA - Arabia Saudita 36
IE - Irlanda 34
UZ - Uzbekistan 34
CZ - Repubblica Ceca 30
AT - Austria 27
CL - Cile 24
TN - Tunisia 24
KE - Kenya 22
PH - Filippine 22
LT - Lituania 19
JM - Giamaica 18
JO - Giordania 17
MY - Malesia 17
AE - Emirati Arabi Uniti 16
EG - Egitto 14
ET - Etiopia 14
NP - Nepal 14
PY - Paraguay 13
BO - Bolivia 10
IR - Iran 10
LB - Libano 10
PE - Perù 10
TH - Thailandia 9
CR - Costa Rica 8
IL - Israele 8
CH - Svizzera 7
OM - Oman 7
PS - Palestinian Territory 7
RS - Serbia 7
AL - Albania 6
AU - Australia 6
AZ - Azerbaigian 6
BH - Bahrain 6
DZ - Algeria 6
UY - Uruguay 6
DO - Repubblica Dominicana 5
GE - Georgia 5
KG - Kirghizistan 5
KR - Corea 5
PA - Panama 5
RO - Romania 5
SR - Suriname 5
TT - Trinidad e Tobago 5
AO - Angola 4
EU - Europa 4
GT - Guatemala 4
HN - Honduras 4
KZ - Kazakistan 4
NG - Nigeria 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TG - Togo 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BW - Botswana 2
BY - Bielorussia 2
HT - Haiti 2
HU - Ungheria 2
KH - Cambogia 2
Totale 29.164
Città #
Ashburn 1.624
Singapore 1.350
Fairfield 1.283
Chandler 1.245
Woodbridge 1.120
San Jose 825
Nyköping 714
Hong Kong 710
Houston 627
Milan 615
Jacksonville 591
Seattle 524
Ann Arbor 523
Cambridge 516
Wilmington 476
Beijing 466
New York 430
Bari 259
Lawrence 233
Los Angeles 231
Roxbury 231
Rome 224
Lauterbourg 219
Nanjing 194
Dallas 183
Des Moines 152
Helsinki 151
Brooklyn 134
Munich 123
Ho Chi Minh City 119
Council Bluffs 118
Inglewood 110
São Paulo 109
Boardman 105
Santa Clara 99
Princeton 93
Buffalo 78
Hanoi 78
San Diego 71
Jakarta 64
Orem 64
London 59
Brussels 58
Abidjan 55
Nanchang 55
Grafing 54
Shenyang 51
Moscow 50
Tokyo 50
Washington 49
Turin 48
Chicago 47
Denver 47
Figino 47
Hebei 47
Paris 47
Johannesburg 46
Frankfurt am Main 45
Warsaw 43
Marseille 42
Toronto 42
Montreal 41
Columbus 40
Rio de Janeiro 40
Dearborn 39
Jiaxing 36
Chennai 35
Dublin 33
Manchester 33
Dong Ket 31
Falkenstein 31
Tashkent 31
San Francisco 30
Tianjin 30
Atlanta 29
Changsha 29
Redwood City 29
Pune 28
Baghdad 27
Belo Horizonte 27
Phoenix 27
Boston 26
Turku 26
Guangzhou 25
The Dalles 24
Amsterdam 23
Nuremberg 23
Brno 22
Dhaka 22
Ankara 20
Brasília 20
Quito 20
Salvador 20
Basingstoke 19
Caracas 19
Stockholm 19
Mumbai 18
Shanghai 18
Bogotá 17
Nairobi 17
Totale 19.107
Nome #
HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia 783
Response to "Is active acid sphingomyelinase required for the antiproliferative response to rituximab?" [e-letter]. http://bloodjournal.hematologylibrary.org/content/117/13/3695.citation/reply#bloodjournal_el_2268 766
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 297
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy 250
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 223
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 223
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 216
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders 212
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases 202
Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma 201
Autoimmune uveitis: clinical, pathogenetic, and therapeutic features 200
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 196
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 193
Mucine-1 is related to cell-mediated immunoexpression and blood pressure in pulmonary artery in pulmonary arterial hypertension (PAH): Preliminary results 191
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 190
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 190
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 189
A spatial view of the CD8(+) T-cell response: the case of HCV 185
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 185
HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 180
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 180
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 180
Autoantibodies Recognizing the Amino Terminal 1-17 Segment of CENP-A Display Unique Specificities in Systemic Sclerosis 179
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 176
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 176
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 175
Dendritic cell maturation in HCV infection: Altered regulation of MHC class I antigen processing-presenting machinery 173
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 171
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 171
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 169
Autoantibodies to intracellular antigens: generation and pathogenetic role 169
Goodpasture's disease: a report of ten cases and a review of the literature. 164
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 164
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 164
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 164
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: In vitro and in vivo studies 163
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma 162
Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques 159
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 158
BL1391: an established cell line from a human malignant peripheral nerve sheath tumor with unique genomic features 158
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 157
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 157
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 157
Age-related differences in human palatine tonsillar B cell subsets and immunoglobulin isotypes 155
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 154
Bortezomib treatment modulates autophagy in multiple myeloma 154
A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target 154
Dendritic cells transfected with cytopathic self-replicating RNA induce crosspriming of CD8+ T cells and antiviral immunity 153
The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review 151
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 150
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 149
Effectiveness and safety of belimumab in patients with active systemic lupus erythematosus: results from a large, nationwide, multicentric study. 149
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 149
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 148
The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy 146
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside 146
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 145
Rheumatic disorders as paraneoplastic syndromes 142
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 141
Flogosis and heart involvement in large vessel vasculitis 141
Common variable immunodeficiency and gastric malignancies 140
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 138
Amyloid heart involvement lead a fast fatal evolution a healthy woman: a case report 138
B cell activation: general to HCV-specific considerations 137
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients 137
Cytotoxic t-lymphocyte antigen-4 in colorectal cancer: Another therapeutic side of capecitabine 137
T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies 136
Effects of Adjuvants for Human Use in Systemic Lupus Erythematosus (Sle)-Prone (Nzb/Nzw) F1 Mice 135
Clonal CD27+ CD19+ B-cell expansion through inhibition of FCgIIR in HCV+ cryoglobulinemic patients 135
Bone marrow dendritic cells induce myeloma cell resistance to CD8+ T cell-mediated killing 135
Extra-articular manifestations of rheumatoid arthritis: an update 134
Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma 134
Cyclosporine-A plus steroids, versus steroids alone, in the 12-month treatment of systemic lupus erythematosus 133
Hepatitis C virus infection, lymphoproliferation and non-Hodgkin’s B cell lymphoma 133
Cancer treatment and the KIR–HLA system: an overview 133
Cross-priming of hepatitis C virus specific CD8+ T cells in mice by immunization with self-replicating RNA transfected dendritic cells 132
In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma 132
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery 132
Alternative splicing of HLA-C mRNA in HCV-infected hepatocytes reduces viral epitope-specific cytotoxicity T cell response and promotes NK activity 132
Actors on the scene: Immune cells in the myeloma niche 132
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 131
Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers 131
In vitro proliferation of naive B cells and memory B cells: different profiles from healthy and HCV-infected individuals 130
Bone marrow of persistently hepatitis C virus-infected individuals accumulates memory CD8+ T cells specific for current and historical viral antigens: A study in patients with benign hematological disorders 130
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 130
Case series on amyloidosis and organ involvement: a single center experience 128
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials 126
The liver as an immunological organ 125
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 124
Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes 124
Hepatitis C virus infection: when silence is deception 123
Carcinogenesis and Metastasis in Liver: Cell Physiological Basis 123
Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcome 122
B-T cell interaction in the pathogenesis of HCV-positive mixed cryoglobulinemia. 121
Vasculitis in connective tissue diseases 121
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection 120
Efficacy of filgrastim, lenograstim and peg-filgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative disorders. 118
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 117
Fever, cough and breathlessness in a patient with digeorge syndrome 117
Dendritic cell maturation in HCV infection: altered regulation of MHC class I antigen processing-presenting machinery 116
Totale 16.817
Categoria #
all - tutte 124.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.000 86 220 43 98 90 134 102 146 110 132 338 501
2022/20233.216 426 438 218 274 331 470 61 359 492 24 74 49
2023/20241.377 98 201 84 82 128 520 38 57 8 21 9 131
2024/20254.379 144 79 335 188 153 398 491 428 167 241 675 1.080
2025/202610.781 1.330 388 445 849 1.142 561 1.136 288 2.313 902 328 1.099
2026/2027176 176 0 0 0 0 0 0 0 0 0 0 0
Totale 30.051